Insights from 2023 ESMO Annual Meeting


 

Newest monarchE Trial Updates Including 5-Year Efficacy Outcomes - Adjuvant Abemaciclib + ET for HR+/HER2- High-Risk eBC

833 views
December 4, 2023
0 Comments
Login to view comments. Click here to Login
Breast